Page - 51 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Image of the Page - 51 -
Text of the Page - 51 -
Cooperet al. Nanoparticles for radiation therapy
Photothermal therapy consisted of 3min of irradiation with a
30mW,808nm laser source.Apoptosiswas seen after treatment
in thepresenceof thegoldparticles.
A recent study (Hainfeld et al., 2010) calculated the radiation
dose required to control 50% of tumors (TCD50) in a mouse
squamous cell carcinomamodel.Goldnanoparticleswere deliv-
ered intratumorally, and24h later the tumorwasheated to48◦C
for5minat 1.5W/cm2 followedbyX-ray irradiationat 100kVp
(7.5Gy/min).TCD50wasreducedfrom55Gyto less than15Gy.
These studies illustrate one of the biggest problems of the
approach,which is theneed for simultaneousdeliveryofheating
and radiation,whichposes logistic problems in the clinic (Wust
etal.,2002).Otherdrawbacks includea lackofspecificityandthe
difficultyofheatingdeeptumors.
ALTERNATIVESTOGOLD:BISMUTHANDIRON
Alternatives toAuarebeingsought thataremoreeffectiveand/or
less costly.Bismuth(Bi,Z=83)andplatinum(Pt,Z=78)have
been shown in at least one theoretical study to yield a dose
enhancement factor higher than Au, with Bi being the high-
est. Dose enhancement is predicted to increase with decreasing
nanoparticle size, because the smaller nanoparticles accumulate
closer to thenucleus,where they can cause the greatest damage.
The dose enhancement is also expected to be greater when the
averageenergy is close to theK-edgeof theelement (Ngwaet al.,
2010;HossainandSu,2012).Aradiochromicdosimeterwasused
in another study to experimentally measure the dose enhance-
ment of bismuth oxide (Bi2O3) nanoparticles. Using a 100kV
X-ray sourceandan irradiationdoseof10Gy, the radiationdose
inawater-equivalentmatrixdopedwith0.5mMof50nmBi2O3
nanoparticles was>80% higher than in the control compart-
ment(Alqathamietal., 2013).Anotherstudy(Zhangetal., 2014)
looked at thedark toxicity, biodistribution, and radiation effects
ofbismuth selenide (Bi2Se3)nanoplatelets in cell lines andmice.
The platelets were not significantly toxic to either cells ormice,
withover93%oftheBiclearedfromthebody90daysafter treat-
ment.Significantradiationdoseenhancementwasobservedafter
irradiationdosesofupto8Gy.
Gadolinium (Gd, Z=64) represents another alternative to
goldnanoparticles. Inaddition tohavinga relativelyhighatomic
number,Gd is already routinelyusedas a contrast agent inMRI.
Gd2O3 core nanoparticles encapsulated in a polysiloxane shell
have shown potential as an image guided radiotherapeutic tool
in a gliosarcoma ratmodel (LeDuc et al., 2011). Accumulation
of the nanoparticles in the tumor after saphenous vein injec-
tion was demonstrated usingMRI, and the tumor-bearing rats
weretreatedwithmicrobeamradiationtherapy,withasignificant
increase in survival in the nanoparticle-treated group. Another
studyusing a rat brain tumormodel confirmed that ultra-small
Gd-based nanoparticles accumulate in brain tumors after IV
injection(Miladietal., 2013).
Magnetic particles such as iron oxide may also be used for
combined hyperthermia and radiation. By using an alternating
magneticfieldtoexcitemagneticnanoparticles, localtemperature
increases can be achieved. The advantages of iron oxide include
low toxicity, ease of synthesis, and the ability to perform image
guidanceusingMRI.Dextran-coated ironoxidehasbeen shown toreducetumorgrowthinasyngeneicmousebreastcancermodel
whenhyperthermiaandradiationwerecombined(Giustinietal.,
2011).
Several studies have looked at radiosensitization properties
of iron oxide nanoparticles. Using 6MeV X-rays on a human
prostatecarcinomacell line(DU145),1mg/mlofFe3O4nanopar-
ticles resulted inadoseenhancement factorof approximately1.2
(Khoeietal., 2014).Anotherstudysuggestedthat superparamag-
netic ironoxidenanoparticles(SPIONs)canradiosensitizetumor
cells by catalyzing ROS formation. Uncoated, citrate-coated, or
malate-coated SPIONswere added toMCF-7, 3T3, andCaco-2
cells. Uncoated SPIONS caused dark toxicity, with no increase
inROSupon 1 or 3Gy irradiation. In contrast, coated SPIONS
were non-toxic in the absence of radiation, but resulted an
increase of up to 300% in the fluorescence intensity of theROS
reporter dichlorofluorescein diacetate (DCF-DA) (Klein et al.,
2014).
SCINTILLATINGNANOPARTICLESFOR
RADIATION/PHOTODYNAMIC“HYBRID”THERAPY
INTRODUCTIONANDCONCEPT
A 2006 study proposed a new approach to nanoparticle-based
therapies aiming to combine and enhance the effects of radi-
ation therapy and photodynamic therapy (PDT) through the
use of scintillating nanoparticles conjugated to photosensitizer
molecules(ChenandZhang,2006).Theconcept is simple:attach
adyeusedforPDTtoananoparticlethatemits lightwhenexcited
bytherapeuticradiation(scintillates). If thescintillationemission
overlapstheabsorbancespectrumofthedye,thedyewillgenerate
singletoxygenas itdoeswith light-excitedPDT(Figure2).Many
conventional photosensitizers are based on naturally occurring
porphyrin, chlorin, andbacteriochlorin structures comprised of
highly conjugated heterocyclic macrocycles (Figure3A). These
moleculeshaveastrongabsorbancepeak in theUVtobluerange
(Soret band) as well as numerous weaker peaks in the visible
(Figure3B).
This idea has attracted significant attentionover the past few
years (Cheng andLo, 2011) because it promises to combine the
tissuepenetrationdepthofradiationwiththeefficacyandbenign
side effect profile of PDT. PDT results in less damage tonormal
tissue thandoesradiationtherapy;doesnot inducescarring;may
be repeated multiple times; andmay spark immune responses
that help destroy the tumor. However, because of the limited
tissue penetration depth of visible and even near-IR light, this
therapy is restricted toonly themost superficial cancers, such as
non-melanomaskincancerandbladdercancer.
The challenge is to develop stable, nontoxic nanoscintillators
thatmay be delivered to cells. Several varieties of doped insula-
tor and semiconductor nanoparticles have been proposed to fill
thisrole.WhilescintillationhasbeendemonstratedforCdSe/ZnS
quantum dots (Létant andWang, 2006), they have poor radia-
tionhardnessanddegraderapidlyunderγ rayexposure(Withers
et al., 2008). As the toxicity of thesematerials is also primarily
related to their chemical degradation, alternatives are necessary.
The development of such alternatives is mostly in early stages.
Althoughmany of the approaches to surface chemistry and tar-
getingthathavebeenusedforgoldcouldbeappliedtotheseother
Frontiers inChemistry | ChemicalEngineering October2014 |Volume2 |Article86 | 51
Cancer Nanotheranostics
What Have We Learnd So Far?
- Title
- Cancer Nanotheranostics
- Subtitle
- What Have We Learnd So Far?
- Authors
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Editor
- Frontiers in Chemistry
- Date
- 2016
- Language
- English
- License
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Size
- 21.0 x 27.7 cm
- Pages
- 132
- Keywords
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Categories
- Naturwissenschaften Chemie